PARAMOL TARGET
Country: Israel
Language: English
Source: Ministry of Health
Patient Information leaflet
(PIL)
11-10-2022
Public Assessment Report
(PAR)
18-08-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ACETYLSALICYLIC ACID; CAFFEINE; PARACETAMOL
Available from:
PADAGIS ISRAEL AGENCIES LTD, ISRAEL
ATC code:
N02BA71
Pharmaceutical form:
CAPLETS
Composition:
ACETYLSALICYLIC ACID 250 MG; CAFFEINE 65 MG; PARACETAMOL 250 MG
Administration route:
PER OS
Prescription type:
Not required
Manufactured by:
PERRIGO COMPANY, USA
Therapeutic group:
ACETYLSALICYLIC ACID, COMBINATIONS WITH PSYCHOLEPTICS
Therapeutic area:
ACETYLSALICYLIC ACID, COMBINATIONS WITH PSYCHOLEPTICS
Therapeutic indications:
For temporary relief of the pain of headache mild to moderate pain associated with migraine, pain of menstrual discomfort and pain accompanied by fever.
Authorization date:
2022-06-30
